Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records von Muros-Le Rouzic, Erwan, Ghiani, Marco, Zhuleku, Evi, Dillenseger, Anja, Maywald, Ulf, Wilke, Thomas, Ziemssen, Tjalf, Craveiro, Licinio

Volltext

Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials von Derfuss, Tobias, Bermel, Robert, Lin, Chien-Ju, Hauser, Stephen L, Kappos, Ludwig, Vollmer, Timothy, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Weber, Martin S, Wang, Jianmei, Jessop, Nikki, Chognot, Cathy, Craveiro, Licinio, Bar-Or, Amit

Volltext

Five-year efficacy outcomes of ocrelizumab in relapsing multiple sclerosis: A propensity-matched comparison of the OPERA studies with other disease-modifying therapies in real-worl... von Muros-Le Rouzic, Erwan, Heer, Yanic, Yiu, Sean, Tozzi, Viola, Braune, Stefan, van Hövell, Philip, Bergmann, Arnfin, Bernasconi, Corrado, Model, Fabian, Craveiro, Licinio

Volltext

An observational study to assess validity and reliability of smartphone sensor-based gait and balance assessments in multiple sclerosis: Floodlight GaitLab protocol von Rinderknecht, Mike D, Zanon, Mattia, Boonstra, Tjitske A, Angelini, Lorenza, Stanev, Dimitar, Chan, Gabriela González, Bunn, Lisa, Dondelinger, Frank, Hosking, Richard, Freeman, Jenny, Hobart, Jeremy, Marsden, Jonathan, Craveiro, Licinio

Volltext

Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis von Hauser, Stephen L, Kappos, Ludwig, Montalban, Xavier, Craveiro, Licinio, Chognot, Cathy, Hughes, Richard, Koendgen, Harold, Pasquarelli, Noemi, Pradhan, Ashish, Prajapati, Kalpesh, Wolinsky, Jerry S.

Volltext

Prediction of Long-term Adherence to Smartphone Sensor-based Tests (Floodlight) (P5-6.016) von McGinley, Marisa, Pointeau, Gregoire, Zanon, Mattia, Leocani, Letizia, Comi, Giancarlo, Lipsmeier, Florian, Craveiro, Licinio, Butzkueven, Helmut

Volltext

Normal B-cell ranges in infants: A systematic review and meta-analysis von Borriello, Francesco, Pasquarelli, Noemi, Law, Lisa, Rand, Kim, Raposo, Catarina, Wei, Wei, Craveiro, Licinio, Derfuss, Tobias

Volltext

COVID-19 in ocrelizumab-treated people with multiple sclerosis von Hughes, Richard, Whitley, Louise, Fitovski, Kocho, Schneble, Hans-Martin, Muros, Erwan, Sauter, Annette, Craveiro, Licinio, Dillon, Paul, Bonati, Ulrike, Jessop, Nikki, Pedotti, Rosetta, Koendgen, Harold

Volltext

A claims-based proxy for the EDSS score in multiple sclerosis using German claims data (1473) von Ghiani, Marco, Rouzic, Erwarn Muros-Le, Brüllinger, Lisa, Maywald, Ulf, Wilke, Thomas, Craveiro, Licinio

Volltext

Longitudinal Multiparametric Quantitative MRI Evaluation of Acute and Chronic Multiple Sclerosis Paramagnetic Rim Lesions von Elkady, Ahmed M, Elliott, Colm, Fetco, Dumitru, Araujo, David, Karimaghaloo, Zahra, Ganzetti, Marco, Clayton, David, Craveiro, Licinio, Kazlauskaite, Agne, Narayanan, Sridar, Arnold, Douglas L, Rudko, David A

Volltext

Clinical Applications of Digital Biomarkers in Multiple Sclerosis: A Systematic Literature Review (P5-6.013) von Cobb, Bryan, Karpowicz, Richard J., Cousin, Chris, Win, Nikki, Boggiano, Tina, Jones, David E., Craveiro, Licinio, Priest, Jessica, Mac, Ami, Teng, Edmond, Dorsey, E. Ray, Sabbagh, Marwan N., Gudesblatt, Mark, Demaerschalk, Bart M., Dodick, David W.

Volltext

Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004) von Bove, Riley, Pietrasanta, Carlo, Oreja-Guevara, Celia, Hellwig, Kerstin, Dobson, Ruth, Vukusic, Sandra, Lin, Chien-Ju, Alvarez, Daniela Goncalves Pereira, Zecevic, Dusanka, Ferreira, Germano, Craveiro, Licinio, Pasquarelli, Noemi, McElrath, Thomas

Volltext

Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis von Ganzetti, Marco, Graves, Jennifer S., Holm, Sven P., Dondelinger, Frank, Midaglia, Luciana, Gaetano, Laura, Craveiro, Licinio, Lipsmeier, Florian, Bernasconi, Corrado, Montalban, Xavier, Hauser, Stephen L., Lindemann, Michael

Volltext

Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis (1147) von Hauser, Stephen L., Kappos, Ludwig, Montalban, Xavier, Craveiro, Licinio, Hughes, Richard, Prajapati, Kalpesh, Koendgen, Harold, Pradhan, Ashish, Wolinsky, Jerry S.

Volltext

Serum Ig Levels and Risk of Serious Infections by Baseline Ig Quartile in the Pivotal Phase III Trials and Open-Label Extensions of Ocrelizumab in Multiple Sclerosis (1173) von Bar-Or, Amit, Bermel, Robert, Weber, Martin S., Hughes, Richard, Lin, Chien-Ju, Wang, Jianmei, Sauter, Annette, Koendgen, Harold, Craveiro, Licinio, Hauser, Stephen L., Derfuss, Tobias

Volltext

Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry von Butzkueven, Helmut, Spelman, Tim, Horakova, Dana, Hughes, Stella, Solaro, Claudio, Izquierdo, Guillermo, Kubala Havrdová, Eva, Grand'Maison, Francois, Prat, Alexandre, Girard, Marc, Hupperts, Raymond, Onofrj, Marco, Lugaresi, Alessandra, Taylor, Bruce, Giovannoni, Gavin, Kappos, Ludwig, Hauser, Stephen L., Montalban, Xavier, Craveiro, Licinio, Freitas, Rita, Model, Fabian, Overell, James, Muros‐Le Rouzic, Erwan, Sauter, Annette, Wang, Qing, Wormser, David, Wolinsky, Jerry S.

Volltext

A multicentre, open label, single-arm, phase 3b study (CONSONANCE) to assess the effectiveness and safety of ocrelizumab in patients with primary and secondary progressive multiple... von Comi, Giancarlo, Bermel, Robert, Bar-Or, Amit, McGinley, Marisa, Arnold, Douglas, Henry, Roland, Benedict, Ralph, Bhargava, Pavan, Butzkueven, Helmut, Chard, Declan, Gherardi, Guy, Howell, Owain, Lebrun-Frenay, Christine, Leocani, Letizia, Kazlauskaite, Agne, Kuenzel, Thomas, Montalban, Xavier, Sormani, Maria Pia, Sellebjerg, Finn, Craveiro, Licinio, Lubetzki, Catherine

Volltext

A multicenter, open label, single-arm, phase 3b study (CONSONANCE) to assess efficacy of ocrelizumab in patients with primary and secondary progressive multiple sclerosis: year 1 i... von Benedict, Ralph, Sormani, Maria Pia, McGinley, Marisa, Arnold, Douglas, Bar-Or, Amit, Bermel, Robert, Bhargava, Pavan, Chard, Declan, Gherardi, Guy, Henry, Roland, Howell, Owain, Lebrun-Frenay, Christine, Leocani, Letizia, Lubetzki, Catherine, Kazlauskaite, Agne, Kuenzel, Thomas, Montalban, Xavier, Sellebjerg, Finn, Comi, Giancarlo, Craveiro, Licinio, Butzkeuven, Helmut

Volltext

Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study von Knapp, Rachel, Hardtstock, Fränce, Krieger, Julia, Wilke, Thomas, Maywald, Ulf, Chognot, Cathy, Muros-Le Rouzic, Erwan, Craveiro, Licinio

Volltext

Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database von Hellwig, Kerstin, Oreja-Guevara, Celia, Vukusic, Sandra, Pietrasanta, Carlo, Mcelrath, Thomas, Dobson, Ruth, Craveiro, Licinio, Ferreira, Germano, Lin, Chien-Ju, Pasquarelli, Noemi, Zecevic, Dusanka, Bove, Riley

Volltext